Have questions? Visit https://www.reddit.com/r/SNPedia

rs36211723

From SNPedia

Orientationminus
Stabilizedminus
Geno Mag Summary
(A;G) 6 Familial hypertrophic cardiomyopathy (possible); but 23andMe v4 data is miscall-prone
(G;G) 0 common in clinvar


Make rs36211723(A;A)
ReferenceGRCh38 38.1/142
Chromosome11
Position47338520
GeneMYBPC3
is asnp
is mentioned by
dbSNPrs36211723
dbSNP (classic)rs36211723
ClinGenrs36211723
ebirs36211723
HLIrs36211723
Exacrs36211723
Gnomadrs36211723
Varsomers36211723
LitVarrs36211723
Maprs36211723
PheGenIrs36211723
Biobankrs36211723
1000 genomesrs36211723
hgdprs36211723
ensemblrs36211723
geneviewrs36211723
scholarrs36211723
googlers36211723
pharmgkbrs36211723
gwascentralrs36211723
openSNPrs36211723
23andMers36211723
SNPshotrs36211723
SNPdbers36211723
MSV3drs36211723
GWAS Ctlgrs36211723
Max Magnitude6

Also known as c.2308G>A, p.Asp770Asn or D770N, the rare minor allele of this variant is reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM), according to [PMID 25611685OA-icon.png].

[PMID 29997392OA-icon.png] Without naming the companies that produced the data, this paper cites two examples of a false positive finding for this SNP in direct-to-consumer genotyping data.

ClinVar
Risk rs36211723(A;A) rs36211723(C;C)
Alt rs36211723(A;A) rs36211723(C;C)
Reference Rs36211723(G;G)
Significance Pathogenic
Disease Hypertrophic cardiomyopathy Primary familial hypertrophic cardiomyopathy Familial hypertrophic cardiomyopathy 4 Cardiovascular phenotype
Variation info
Gene MYBPC3
CLNDBN Hypertrophic cardiomyopathy Primary familial hypertrophic cardiomyopathy Familial hypertrophic cardiomyopathy 4 Cardiovascular phenotype
Reversed 1
HGVS NC_000011.9:g.47360071C>G; NC_000011.9:g.47360071C>T
CLNSRC Children's Hospital of Eastern Ontario
CLNACC RCV000461880.1, RCV000030282.4, RCV000161126.5, RCV000205565.2, RCV000252505.1,



[PMID 15519027] Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.


[PMID 16858239] A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.


[PMID 18273486OA-icon.png] MYBPC3 gene variations in hypertrophic cardiomyopathy patients in India.


[PMID 18533079] Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy.